CoChat
Sign Up
Cited by 522Advanced Biosensing Techniques and ApplicationsAdvanced Fluorescence Microscopy TechniquesReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

HTRF: A Technology Tailored for Drug Discovery - A Review of Theoretical Aspects and Recent Applications

Open access
Degorce, Francois·2009·Current Chemical Genomics
DOI 10.2174/1875397300903010022PMC PMC2802762
Open this paper in CoChat — free accountOpen PDF

Abstract

HTRF (Homogeneous Time Resolved Fluorescence) is the most frequently used generic assay technology to measure analytes in a homogenous format, which is the ideal platform used for drug target studies in high-throughput screening (HTS). This technology combines fluorescence resonance energy transfer technology (FRET) with time-resolved measurement (TR). In TR-FRET assays, a signal is generated through fluorescent resonance energy transfer between a donor and an acceptor molecule when in close proximity to each other. Buffer and media interference is dramatically reduced by dual-wavelength detection, and the final signal is proportional to the extent of product formation. The HTRF assay is usually sensitive and robust that can be miniaturized into the 384 and 1536-well plate formats. This assay technology has been applied to many antibody-based assays including GPCR signaling (cAMP and IP-One), kinases, cytokines and biomarkers, bioprocess (antibody and protein production), as well as the assays for protein-protein, proteinpeptide, and protein-DNA/RNA interactions.Since its introduction to the drug-screening world over ten years ago, researchers have used HTRF to expedite the study of GPCRs, kinases, new biomarkers, protein-protein interactions, and other targets of interest. HTRF has also been utilized as an alternative method for bioprocess monitoring. The first-generation HTRF technology, which uses Europium cryptate as a fluorescence donor to monitor reactions between biomolecules, was extended in 2008 through the introduction of a second-generation donor, Terbium cryptate (Tb), enhancing screening performance. Terbium cryptate possesses different photophysical properties compared to Europium, including increased quantum yield and a higher molar extinction coefficient. In addition to being compatible with the same acceptor fluorophors used with Europium, it can serve as a donor fluorophore to green-emitting fluors because it has multiple emission peaks including one at 490 nm. Moreover, all Terbium HTRF assays can be read on the same HTRF-compatible instruments as Europium HTRF assays.Overall, HTRF is a highly sensitive, robust technology for the detection of molecular interactions in vitro and is widely used for primary and secondary screening phases of drug development. This review addresses the general principles of HTRF and its current applications in drug discovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/1875397300903010022

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. (1) The general principle of fluorescence resonance energy transfer technology (FRET). When the donor and acceptor apart, there is no FRET signal. Once they are brought in proximity, the FRET signals are generated (for example, the emission spectrum at 665 nm).
Fig. (1) The general principle of fluorescence resonance energy transfer technology (FRET). When the donor and acceptor apart, there is no FRET signal. Once they are brought in proximity, the FRET signals are generated (for example, the emission spectrum at 665 nm).CC BY-NC · PubMed Central
Fig. (2) The energy pulse from the excitation source (flash lamp, laser) is followed by a time delay, allowing interfering short-lived fluorescence (compounds, proteins, medium etc.) to decay. The red line: FRET signal intensity generated at 665 nm; black line, emission of donor cryptate at 620 nm; orange line, fluorescent signal generated from acceptor fluorophores.
Fig. (2) The energy pulse from the excitation source (flash lamp, laser) is followed by a time delay, allowing interfering short-lived fluorescence (compounds, proteins, medium etc.) to decay. The red line: FRET signal intensity generated at 665 nm; black line, emission of donor cryptate at 620 nm; orange line, fluorescent signal generated from acceptor fluorophores.CC BY-NC · PubMed Central
Fig. (3) Features of donor cryptate. a. Structure of cryptate trisbipyridine (TBP). Lambda max absorption: 305nm, molar extinction coefficient at 305nm: 30000 M-1 cm-1, molar extinction coefficient 337nm: 4500 M-1 cm-1. b. Detection wavelengths for Europium and Terbium cryptate. Both Europium and Terbium have emission spectra at 620 nm so that these signals can be used as reference for data analysis.
Fig. (3) Features of donor cryptate. a. Structure of cryptate trisbipyridine (TBP). Lambda max absorption: 305nm, molar extinction coefficient at 305nm: 30000 M-1 cm-1, molar extinction coefficient 337nm: 4500 M-1 cm-1. b. Detection wavelengths for Europium and Terbium cryptate. Both Europium and Terbium have emission spectra at 620 nm so that these signals can be used as reference for data analysis.CC BY-NC · PubMed Central
Fig. (4). Ratiometric reduction of the signal output data. The specific signal at 665 nm may be affected by light transmission. The ratio (i.e. 665nm/620 nm) will normalize the signal measured and generate a variable that is independent of the optical properties of the medium in which the interaction is studied. In the case shown above, the 665 nm fluorescence decreases proportionally to the transmission, whereas the ratio corrects this interference and is equivalent in both situations.
Fig. (4). Ratiometric reduction of the signal output data. The specific signal at 665 nm may be affected by light transmission. The ratio (i.e. 665nm/620 nm) will normalize the signal measured and generate a variable that is independent of the optical properties of the medium in which the interaction is studied. In the case shown above, the 665 nm fluorescence decreases proportionally to the transmission, whereas the ratio corrects this interference and is equivalent in both situations.CC BY-NC · PubMed Central
Fig. (5) cAMP assay principle. In this competitive assay, an anti-cAMP antibody is labeled with a cryptate donor and cAMP is labeled with acceptor d2. Once both of them are place together, the binding of antibody to cAMP brings donor and acceptor into proximity range. Upon the excitation of donor at 337 nm, the energy is transferred from donor to acceptor. Donor and acceptor generate emission at 620 nm and 665 nm, respectively. In the cAMP assay, the level of free cAMP generated by the signal cascade can be measured by competing with the cAMP d2 for antibody binding. IP-One assay from HTRF has the similar principle.
Fig. (5) cAMP assay principle. In this competitive assay, an anti-cAMP antibody is labeled with a cryptate donor and cAMP is labeled with acceptor d2. Once both of them are place together, the binding of antibody to cAMP brings donor and acceptor into proximity range. Upon the excitation of donor at 337 nm, the energy is transferred from donor to acceptor. Donor and acceptor generate emission at 620 nm and 665 nm, respectively. In the cAMP assay, the level of free cAMP generated by the signal cascade can be measured by competing with the cAMP d2 for antibody binding. IP-One assay from HTRF has the similar principle.CC BY-NC · PubMed Central
Fig. (6) The comparison of “sandwich” assay and competition assay. a. “Sandwich” assay. HTRF signals are generated through the energy transfer from donor to acceptor that are labeled on the antibodies recognizing the target at different regions. b. Competition assay. Targets generated through biological events compete binding activity to the donor labeled antibody with the target labeled with acceptor so that the decrease of the HTRF signals are measured.
Fig. (6) The comparison of “sandwich” assay and competition assay. a. “Sandwich” assay. HTRF signals are generated through the energy transfer from donor to acceptor that are labeled on the antibodies recognizing the target at different regions. b. Competition assay. Targets generated through biological events compete binding activity to the donor labeled antibody with the target labeled with acceptor so that the decrease of the HTRF signals are measured.CC BY-NC · PubMed Central
Fig. (7) Kinase assay principle. The substrates used in HTRF kinase assays are tagged by fusion proteins, peptides, or biotin. An antibody to these proteins or peptides, or streptavidin (for biotin in this case) is labeled with acceptor. An antibody against phosphorylated substrate is labeled by donor cryptate. In the enzymatic reaction, once substrate is phosphorylated, donor and acceptor can be brought into proximity by affinity interactions of antibodies/substrate or streptavidin/biotin.
Fig. (7) Kinase assay principle. The substrates used in HTRF kinase assays are tagged by fusion proteins, peptides, or biotin. An antibody to these proteins or peptides, or streptavidin (for biotin in this case) is labeled with acceptor. An antibody against phosphorylated substrate is labeled by donor cryptate. In the enzymatic reaction, once substrate is phosphorylated, donor and acceptor can be brought into proximity by affinity interactions of antibodies/substrate or streptavidin/biotin.CC BY-NC · PubMed Central
Fig. (8) Principle of protein-protein interaction. Antibodies against the desired proteins (CD28 and CD 86 as examples) for interaction or the fused tags on these proteins are labeled with donor and acceptor, respectively. The FRET signals are generated once these proteins interact with each other to bring the labeled antibodies in into proximity.
Fig. (8) Principle of protein-protein interaction. Antibodies against the desired proteins (CD28 and CD 86 as examples) for interaction or the fused tags on these proteins are labeled with donor and acceptor, respectively. The FRET signals are generated once these proteins interact with each other to bring the labeled antibodies in into proximity.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 74 references

Research works printed but not linked: 1

  1. [23]Amoravain M Lyotard S Jaga D Lebreton ML Servent F Bomer U Introduction of a new HTRF acceptor, d2: Development of a complete GPCR platform for a Gs, Gi and Gq screening SBS 2005 11th Annual Conference Geneva

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Degorce, F.
Venue
Current Chemical Genomics
Publisher
Bentham Science Publishers Ltd.
Published
2009-03-17
Volume
3
Issue
1
Pages
22-32
ISSN
1875-3973 (ISSN-L)
DOI
10.2174/1875397300903010022
PMC
PMC2802762
OpenAlex
W2073113196
Cited by
501
References
74
Citations by year
2026: 29 · 2025: 31 · 2024: 35 · 2023: 37 · 2022: 31 · 2021: 53 · 2020: 35 · 2019: 29 · 2018: 34 · 2017: 28 · 2016: 23 · 2015: 25 · 2014: 39 · 2013: 28 · 2012: 26
FWCI
5.90
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Current Chemical Genomics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Advanced Fluorescence Microscopy Techniques
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
homogeneous time-resolved fluorescence, time-resolved fluorescence resonance energy transfer, drug discovery, high-throughput screening, fluorescence resonance energy transfer, europium cryptate, G protein-coupled receptor signaling, kinase activity assay, protein-protein interaction, bioprocess monitoring, antibody-based assays, biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review